Results
|
|
1.
|
|
|
|
2.
|
A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products. [electronic resource] by
- Lonial, Sagar
- Hicks, Michelle
- Rosenthal, Hilary
- Langston, Amelia
- Redei, Istvan
- Torre, Claire
- Duenzl, Mary
- Feinstein, Bonita
- Cherry, Judith
- Waller, Edmund K
Producer: 20050511
In:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 10
Availability: No items available.
|
|
|
3.
|
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. [electronic resource] by
- Lonial, Sagar
- Akhtari, Mojtaba
- Kaufman, Jonathan
- Torre, Claire
- Lechowicz, Mary J
- Flowers, Christopher
- Sinha, Rajni
- Khoury, Hanna J
- Langston, Amelia A
- Waller, Edmund K
Producer: 20130730
In:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 19
Availability: No items available.
|
|
|
4.
|
MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells. [electronic resource] by
- Gu, Yanyan
- Kaufman, Jonathan L
- Bernal, Leon
- Torre, Claire
- Matulis, Shannon M
- Harvey, R Donald
- Chen, Jing
- Sun, Shi-Yong
- Boise, Lawrence H
- Lonial, Sagar
Producer: 20140902
In:
Blood vol. 123
Availability: No items available.
|
|
|
5.
|
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes. [electronic resource] by
- David, Ebenezer
- Kaufman, Jonathan L
- Flowers, Christopher R
- Schafer-Hales, Katherine
- Torre, Claire
- Chen, Jing
- Marcus, Adam I
- Sun, Shi-Yong
- Boise, Lawrence H
- Lonial, Sagar
Producer: 20110106
In:
Blood vol. 116
Availability: No items available.
|
|
|
6.
|
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study. [electronic resource] by
- Lonial, Sagar
- Kaufman, Jonathan
- Tighiouart, Mourad
- Nooka, Ajay
- Langston, Amelia A
- Heffner, Leonard T
- Torre, Claire
- McMillan, Stephanie
- Renfroe, Heather
- Harvey, R Donald
- Lechowicz, Mary J
- Khoury, H Jean
- Flowers, Christopher R
- Waller, Edmund K
Producer: 20101214
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16
Availability: No items available.
|
|
|
7.
|
Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma. [electronic resource] by
- Lonial, Sagar
- Waller, Edmund K
- Richardson, Paul G
- Jagannath, Sundar
- Orlowski, Robert Z
- Giver, Cynthia R
- Jaye, David L
- Francis, Dixil
- Giusti, Sara
- Torre, Claire
- Barlogie, Bart
- Berenson, James R
- Singhal, Seema
- Schenkein, David P
- Esseltine, Dixie-Lee W
- Anderson, Jessica
- Xiao, Hugh
- Heffner, Leonard T
- Anderson, Kenneth C
Producer: 20060118
In:
Blood vol. 106
Availability: No items available.
|